4//SEC Filing
Pasternak Andy 4
Accession 0001842952-25-000078
CIK 0001842952other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:30 PM ET
Size
5.5 KB
Accession
0001842952-25-000078
Insider Transaction Report
Form 4
Pasternak Andy
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+138,900→ 138,900 totalExercise: $0.65Exp: 2035-06-11→ Common Stock (138,900 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001792746
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 5:30 PM ET
- Size
- 5.5 KB